ADAM9 and posterior cortical atrophy: ADAM9 harbors extracellular matrix (ECM) proteolytic activity and was reported to be overexpressed in PCa tissues, particularly in patients who had received ADT, and is known to be associated with PCa progression, radiosensitivity, chemosensitivity, and biochemical recurrence28–31.